TRCT
TSVT

Tower Research Capital (TRC)’s 2seventy bio TSVT Stock Holding History

Tower Research Capital (TRC)’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,912
Closed -$14.4K – 5575
2025
Q1 		$14.4K Sell
2,912
-1,516
-34% -$4.82K ﹤0.01% 3298
2024
Q4 		$13K Buy
4,428
+1,773
+67% +$7.27K ﹤0.01% 3565
2024
Q3 		$12.5K Sell
2,655
-5,622
-68% -$25.4K ﹤0.01% 3579
2024
Q2 		$31.9K Buy
8,277
+5,540
+202% +$25K ﹤0.01% 3440
2024
Q1 		$14.6K Sell
2,737
-11,892
-81% -$55.9K ﹤0.01% 3301
2023
Q4 		$62.5K Buy
14,629
+1,925
+15% +$5.92K ﹤0.01% 2980
2023
Q3 		$49.8K Sell
12,704
-12,722
-50% -$83.4K ﹤0.01% 2553
2023
Q2 		$257K Buy
25,426
+23,396
+1,153% +$248K 0.01% 1390
2023
Q1 		$21K Buy
2,030
+1,032
+103% +$11.8K ﹤0.01% 3398
2022
Q4 		$10K Sell
998
-8,428
-89% -$119K ﹤0.01% 4084
2022
Q3 		$137K Sell
9,426
-4,225
-31% -$62.7K ﹤0.01% 2269
2022
Q2 		$180K Buy
13,651
+11,132
+442% +$152K ﹤0.01% 1849
2022
Q1 		$43K Sell
2,519
-4,488
-64% -$76.1K ﹤0.01% 2862
2021
Q4 		$180K Buy
+7,007
New +$219K ﹤0.01% 1853

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tower Research Capital (TRC)'s TSVT Position: Q2 2025 in Review

Tower Research Capital (TRC) sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 2,912 shares — an estimated $14.4K sold.

Tower Research Capital (TRC) first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $257K in Q2 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Tower Research Capital (TRC) reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,912 2seventy bio shares in Q2 2025, an estimated $14.4K.
  • Tower Research Capital (TRC) first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Tower Research Capital (TRC)'s 2seventy bio position peaked at $257K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.